Shattuck Labs Announces Participation in Upcoming September Investor Conferences

AUSTIN, Texas and DURHAM, N.C., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potential first-in-class monoclonal and bispecific DR3 blocking antibodies for the treatment of patients with inflammatory and immune-mediated diseases, today announced that company management will present at and participate in the following upcoming investor conferences:

Conference Details

Wells Fargo 21 st Annual Healthcare Conference

Format: Fireside chat and one-on-one meetings Presenter: Taylor Schreiber, M.D., Ph.D., Chief Executive Officer Additional Management Participant: Andrew Neill, M.B.A., Chief Financial Officer Presentation Date: September 8, 2026 Time: 11:00 AM ET Webcast link: HERE

Cantor Global Healthcare Conference

Format: Fireside chat and one-on-one meetings Presenter: Taylor Schreiber, M.D., Ph.D., Chief Executive Officer Additional Management Participant: Andrew Neill, M.B.A., Chief Financial Officer Presentation Date: September 9, 2026 Time: 3:55 PM ET Webcast link: HERE

Interested parties can access live audio webcasts of these presentations via the Investor Relations section of the company’s website at www.shattucklabs.com . Replay webcasts will be available for approximately 30 days following the live presentations.

About Shattuck Labs, Inc. Shattuck Labs, Inc. is a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3 blocking antibodies for the treatment of patients with inflammatory and immune-mediated diseases. Shattuck’s expertise in protein engineering and the development of novel TNF receptor therapeutics come together in its lead program, SL-325, a potentially first-in-class DR3 antagonist antibody designed to achieve a more complete blockade of the clinically validated DR3/TL1A pathway. The Company has offices in both Austin, Texas and Durham, North Carolina. For more information, please visit: www.ShattuckLabs.com .

Investor & Media Contact: Andrew R. Neill Chief Financial Officer Shattuck Labs, Inc. [email protected]